|
"occurred in ir; did not occur in cardiac cath lab.As the zilver vena was attempted to be deployed, the inari sheath gripped on the outer shaft of the stent, and caused the separation of the outer sheath.Did not cause total separation of the device (still in 1 piece).User was able to safely remove form the patient.No patient injury.Proceeded by deploying a different zilver device (as they didn't have the same gpn available).User determined that they needed to push the 2 grey buttons on the inari introducer sheath to allow for passage of the zilver stent.Inari rep, also present, said they'd never seen that happen either.1.Did any unintended section of the device remain inside the patient¿s body? no ¿ if yes, please describe.2.Was the patient hospitalized or was there prolonged hospitalization due to this occurrence? no.¿ if yes, please describe.3.Did the patient require any additional procedures due to this occurrence? no ¿ if yes, please describe.4.Did the product cause or contribute to the need for additional procedures? no ¿ if yes, please specify additional procedures and provide details.5.Has the complainant reported any adverse effects on the patient due to this occurrence? no.6.Has the complainant reported that the product caused or contributed to the adverse effects? no.¿ please specify adverse effects and provide details.Prefix zvt7 3.94 are images of the device or procedure available? n/a,yes,no no.3.95 did the patient have pre-existing conditions? n/a, yes, no asku.¿ if yes, please specify: 3.96 please describe the native state of the vessel (i.E.Was the anatomy tortuous? was the vessel fibrotic?) n/a, tortuous, calcified, fibrotic, other; thrombotic but unrelated ¿ if other, please specify: 3.97 was a stent previously placed during previous procedures? n/a, yes, no; no.3.98 was the device used percutaneously? n/a,yes,no; yes.3.99 where on the patient was the percutaneous access site? popliteal 3.100 was the access site jugular or femoral? n/a, jugular, femoral other ¿ if other, please specify:; n/a 3.101 what disease pathology was being treated? may thurner, acute or chronic obstruction, restenosis, other? may thurner ¿ if other, please specify 3.102 was the lesion approached via contralateral or ipsilateral? n/a, contralateral, ipsilateral; ipsilateral 3.103 was pre-dilation performed ahead of placement of the stent? n/a, yes, no; yes 3.104 what was the target location for the stent? common iliac vein, external iliac vein 3.105 details of access sheath used (name, fr size, length)? inari, 14 or 16 french 3.106 was the device flushed through both flushing ports before the procedure, as per ifu? n/a,yes,no; yes 3.107 details of the wire guide used (name, diameter, hydrophylic)? amplatz extra support.035 3.108 was resistance encountered when advancing the wire guide to the target location? n/a, yes, no; no 3.109 was resistance encountered when advancing the delivery system to the target location? n/a, yes, no; no 3.110 if resistance was met, how did the physician address this? n/a 3.111 did the tip of the delivery system cross the target location? n/a,yes,no; yes 3.112 did the user pull the handle towards the hub during deployment, per ifu? n/a,yes,no; yes 3.113 did the user push the hub during deployment? n/a, yes, no; no 3.114 did the user remove slack in the delivery system before deployment, per ifu? n/a, yes, no; yes 3.115 was the stent deployed smoothly / without resistance? n/a, yes, no; no 3.116 was the stent fully deployed in the patient? n/a, yes, no; no 3.117 was the stent fully deployed before removing the delivery system from the patient? n/a, yes, no; no 3.118 was post dilation performed after the placement of the stent? n/a, yes, no; n/a wasn't deployed 3.119 was the delivery system damaged/kinked/twisted during deployment? n/a, yes, no; cut in half (circumferentially detached) from proximal 3.120 what intervention (if any) was required? no 3.121 was the secondary intervention performed during the same procedure as the device failure or was it scheduled for another day? n/a, same procedure, another day; no 3.122 were any other defects (other than the complaint issue) observed on the delivery system prior to return (e.G.Kink)? n/a, yes, no; no ¿ please specify if yes.
|